DAFTAR PUSTAKA

1. Weatherall, DJ. The Thalassemias. Williams hematology. 6th edition. Mc-Graw

Hill,November 2000.2

2. Weatherall, DJ, Clegg Jb. Thalassemia Syndromes. 4rd edition.Blackwell

science.UK.2001

3. Pignatti CB, Galanello R.Thalassemias and Related disorders: Quantitative Disorderd

of Hemoglobin Synthesis. In: Wintrobe’s Clinical Hematology. Lipincot Williams &

Wilkins. Philadelphia.2009;C 39:p.1084-1130

4. Langlois S, Ford JC, Chitayat D. Carrier Screening for Thalassemia and

Hemoglobinopathies in canada. Joint SOGC-CCMG Clinical Practice Guidline 2008,

218: 950-959

5. World Health Organization/Thalassemia International Federation. Prosiding dari: Joint

meeting on the prevention and control of haemoglobinopathies. Nicosia-cyprus: World

Health Organization/Thalassemia International Federation, 1994:20

6. World Health Organization/Thalassemia International Federation. Prosiding dari: Joint

meeting on the prevention and control of haemoglobinopathies. Nicosia-cyprus: World

Health Organization/Thalassemia International Federation, 2007:1

7. Thalassemia International Federation. 2012 Activity Plan, 2012:5

8. Elizabeth G. Genotype-phenotype Diversity of Beta-Thalassemia in malaysia:

Treatment Options and Emerging Therapies.

9. Galanello R, Eleftheriou A, Synodinos JT, Old J, Petrou M, Angastiniotis M. In:

Prevention of Thalassemias and other Haemoglobin Disorders. Thalassemia

International Federation. Nicosia Cyprus:2005

10. Health Technology Assessment Indonesia Pencegahan Thalassemia. Irjen Bina

Pelayanan Medik Kementrian Kesehatan Republik Indonesia

39

Universitas Sumatera Utara

11. Wahidayat I, Wahidayat PA. Genetic problems at present and their challenges in the

future: Thalassemia as a model. Pediatrica Indonesiana. 2006:189-194

12. Ganie RA, in : Kajian DNA thalassemia Alpha di Medan. USU press. 2004.

13. Eleftheriou A. What is the thalassemia. Thalassaemia International Federation.

Nicosia-Cyprus, 2003.

14. Wirawan R. Analisa Hemoglobin dengan cara konvensional dan mikrokapiler

elektroforesis. Jakarta. Balai Penerbit FKUI, 2011;h.78.

15. Old J, Synodinos JT, Galanello R, Petrou M, Angastiniotis M. Prevention of

Thalassaemias and other Haemoglobin Disorders. Thalassaemia International

Federation. Nicosia-Cyprus; 2004

16. Higgins TN, Kajuria A, and Mack M, Quantification of HbA2 in Patient With and

Without β-Thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab

Hemoglobin Variants. Comparison of two System. Am J Clin Pathol 2009;131:357-

362.

17. Yang Z, Chaffin CH, Easley PL, Thigpen B, and Reddy VV,MD. Prevalence of

Elevated hemoglobin A2 Measured by the CAPILLARYS System. Am J Clin Pathol,

2009;1311:42-48.

18. Srivorakun H, Fucharoen G, Changtrakul Y, Komwilaisak P, n Fucharoen S.

Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic

assessment using capillary electrophoresis system. Clinical Biochemistry. Published

by Elsevier Inc. 2011; 406-411.

19. Rachmilewitz EA, and Giardina PJ. How I Treat Thalassemia, in:How I Treat. Blood,

2011;3479-3488.

20. Galanello R and Origa R. Beta-Thalassemia. Orphanet Journal Of Rare Diseases 2010.

40

Universitas Sumatera Utara

21. Giordano PC. Carrier Diagnostic and Prevention of Hemoglobinopathies Using

Capillary Electrophoresis. In: Companioin Handbook for the physician, the laboratory

doctor and tge genetic counselor. Paris: Laboratories SEBIA. 2007

22. Bain BJ. Haemoglobin and the genetic of haemoglobin synthesis, in:

Haemoglobinopathy. Second Edition. Blackwell Publishing. 2006;p.1-25

23. Bernard G.Forget and Ross C.Hardison. The Normal Structure and Regulation of

Human Globin Gene Cluster, in: Disorders of Hemoglobin. Genetics,

Pathophysiology, and Clinical. Cambridge University Press. New York. 2009;p.46-61

24. About Alpha Thalassemia. In: Hemoglobin Disorders Hemoglobinopathies.

Thalassemia International Federation. 2007.

25. Ghodekar SR, Gramurohit ND, Kadam SS, and Thorat RM. Thalassemia: A Review.

International Journal of Pharma research and Development-Online (IJPRD).2010.

26. Dimitris L,Leukopoulos. Haemoglobinophaties. Macmillan Plubisher Ltd. 2002.

27. Weatherall DJ. Fortnightly review: The Thalassemias. BMJ, 1997; 1-21.

28. John M,Old. DNA Diagnosis of Hemoglobin Mutations. In:Hemoglobin Disorde

Molecular and Protocols. Humana Press Inc. Totowa,NJ,2003,Vol 82; 101-108.

29. Bernard G, Forget MD. Progress in Understanding the Hemoglobin Switch. N Engl J

Med 2011;365:9

30. Chui DH, Cunningham MJ, Lou Hy, Wolf LC, Neufeld EJ, and Steinberg MH.

Screening and counseling for Thalassemia. Blood 2006;vol 107.Number 4

31. Bain BJ. The α, β, δ dan γ Thalassaemias and related conditions, in:

Hemoglobinopathy. Second Edition. Blackwell Publishing.2006;p:63-138

32. Rozenberg G. Haemoglobin Disrorders, in: Microscopic 3e Haematology a Practical

Guide for The Laboratory. Elsevier. Australia. 2011;p:23-33

33. Rund D and Rachmilewitz E. Β-thalassemia. N ENGL J MED, 353;11

41

Universitas Sumatera Utara

34. Atmakusuma D. Thalassemia: Manifestasi Klinis , Pendekatan diagnosis, dan

Thalassemia Intermedia. Dalam: Ilmu Penyakit Dalam. Internal Publishing. Jilid II,

Edisi V, Bab 220; 1387-1405.

35. Fucharoen S, Winichagoon P.in: New updating into hemoglobinopathies. International

Journal of laboratory Hematology. Blackwell Publishing Ltd. 2012:559-565.

36. Giordano PC. Strategies for basic laboratory diagnostics of the hemoglobinopathies in

multi-ethnic societies: interpretation of results and pitfalls. International Journal of

laboratory Hematology. Blackwell Publishing Ltd. 2012; 1-15.

37. Eldor A and Rachmilewitz EA. The Hypercoagulable State in thalassemia.

38. Olivieri NF and Weatherall DJ. Clinical Aspects of Thalassemia and

39. Mosca A, Paleari R, Ivaldi G, Galanello R, dan Giordano PC. The role of haemoglobin

A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin

Pathol 2009;62:13–17.

40. Mais DD, Gulbranson RD, and Keren DF. The Range of Hemoglobin A2 in

hemoglobin E Heterozygotes as Determined by Capillary Electrophoresis. Am J Clin

Pathol 2009;132:34-38.

41. Insert Kit Sebia MINICAP HEMOGLOBIN (E) ref.2207;2008

42. Minicap hemoglobin training manual,version 7.4.2.January 2010. SEBIA

43. Weatherall, DJ, Clegg Jb. Thalassemia Syndromes. 4rd edition.Blackwell

science.UK.Oxford.2001. 13;586-587.

44. Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the

haaemoglobinopathies. Bailliere’s Clinical Haematology 1998; 215-238.

45. Cao A. Carrier Screening and Genetic Counselling in β-Thalassemia. International

Journal of Hematology 76.2002.Suplement II;105-113

46. Moafi A, Valian S, Nikyar Z, et all. Prevalence of Minor β-thalassemia Based on RBC

Indices among Final Suspected Individuals in Premarital Screening Program Referred

42

Universitas Sumatera Utara

 to Genetic Laboratories. International Journal of Hematology Oncology and Stem Cell

Research (IJHOSCR), Jan., 2010;23-27.

47. Weatherall, DJ, Clegg Jb. Thalassemia Syndromes. 4rd edition.Blackwell

science.UK.Oxford.2001. 14;597-611

48. Bain BJ, Bate I, Laffan MA, Lewis SM. Dacie and Lewis Practical Haematology.

Eleventh edition. Churchill Livingstone Elsevier.2011. 14;301-332.

49. George E, Jamal A, Khalid F, Osman KA. High Performance Liquid Chromatography

(HPLC) As a screening tool for classical beta-thalassemia trait in Malaysia. Malaysian

Journal of Medical Science, Vol 8, No 2. July 2001 (40-46).

50. Ganie, RA. 2004. Studi DNA Thalassemia-α⁰ Southeast Asian Type di Medan.

Naskah Disertasi, Universitas Sumatera Utara.

51. Bain BJ. Other significant haemoglobinopathies. In: Haemoglobinopathy Diagnosis.

Second Edition. Blackwell Publishing. 2006. 5:190-233.

52. Fucharoen S, Weatherall DJ. Hemoglobin E Disorders. In : Disorders of hemoglobin

Genetics, Pathophysiology, and Clinical Management. Cambridge University Press

2009. New York. Second Edition. 18; 417-433.

43

Universitas Sumatera Utara